Form 4 for CLX Clorox
Accepted 2021-09-23 00:00:00 ET · period of report 2021-09-21 · accession 0001225208-21-012521 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-23 | 2021-09-21 | CLX | GARNER DENISE | SVP - Chief Innovation Off | A - Grant | $163.77 | +793 | 11.0K | +8% | +$129.9K |
| D | 2021-09-23 | 2021-09-22 | CLX | GARNER DENISE | SVP - Chief Innovation Off | F - Tax | $162.19 | -53 | 11.0K | -0.5% | -$8,596 |
| D | 2021-09-23 | 2021-09-21 | CLX | GARNER DENISE | SVP - Chief Innovation Off | A - Grant | $0.00 | +5,836 | 5,836 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-21 | A | A | 793 | $163.77 | 11,047 | D | — | — | |
| 2 | Common | Common Stock | 2021-09-22 | F | D | 53 | $162.19 | 10,996 | D | — | — | (F3) Includes 2 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan. |
| 3 | Derivative | Stock Option (Right to Buy) | 2021-09-21 | A | A | 5,836 | $0.00 | 5,836 | D | $163.77 · 2022-10-05 to 2031-09-21 | 5,836 Common Stock | (F4) Option vests in 4 equal installments on each of October 5 of 2022, 2023, 2024 and 2025. |